4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-021140
Chief Financial Officer sold 3,000 shares at $8.33 ($24,990)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-03-24 | Sale | −3,000 | $8.33 | $24,990 | 111,201 | D |
| Open-market sales · 3,000 sh · avg $8.33 · $24,990 | |||||||
Loading xslF345X04/doc4.xml…